Tranexamic Acid.

The brightening active that works where others can’t.

Tranexamic acid ~ TXA ~ arrived in skincare from medicine, where it has been used for decades as a treatment for abnormal bleeding. Its mechanism in the skin is equally precise ~ it interrupts the signal between UV-stimulated keratinocytes and melanocytes, blocking the communication pathway that triggers melanin overproduction at the source rather than simply addressing pigmentation after it has already formed.

This makes TXA fundamentally different from most brightening actives. Vitamin C brightens by inhibiting tyrosinase ~ the enzyme involved in melanin synthesis. Niacinamide reduces melanin transfer between cells. AHA exfoliates pigmented cells from the surface. TXA works upstream of all of these ~ preventing the signal that initiates pigmentation in the first place. Used alongside other brightening actives, it does not simply add to the effect. It multiplies it.

What makes TXA particularly compelling for the Korean skincare approach is its tolerability. Where kojic acid can irritate, where high-concentration vitamin C can sting, and where hydroquinone carries significant safety concerns with long-term use, tranexamic acid is gentle enough for sensitive and reactive skin, compatible with almost every other active in a routine, and clinically proven to address even the most stubborn forms of hyperpigmentation ~ melasma, post-inflammatory pigmentation, hormonal dark spots, and sun damage that vitamin C and niacinamide alone cannot fully resolve.

Korea formulates TXA alongside glutathione, niacinamide, and vitamin C in targeted brightening systems ~ each ingredient addressing pigmentation at a different point in the melanin production pathway for a comprehensive correction that single-active brightening products cannot achieve.

Best for: melasma, stubborn hyperpigmentation, hormonal dark spots, post-inflammatory pigmentation, sensitive skin, brightening.